Abstract
Several studies have shown that schizophrenic patients and their biological relatives generate a greater number of leading saccades during smooth pursuit eye movement (SPEM) tasks. This abnormality may reflect a failure of cortical and/or cerebellar areas to coordinate saccadic and pursuit eye movements during visual tracking. The pharmacology of this phenomenon is not known. Here, we sought to replicate and extend the findings of Olincy et al (1998), who found that nicotine transiently reduced the number of leading saccades during SPEMs. A total of 27 subjects with schizophrenia (17 males; 14 smokers), and 25 healthy comparison subjects (nine males; 14 smokers) completed an eye-tracking task after receiving a 1.0 mg nasal spray of nicotine and during drug-free conditions. Results confirm that nicotine reduces the number of leading saccadic eye movements during visual tracking in schizophrenic patients. Baseline impairments and the beneficial effects of nicotine were not restricted to patient smokers, as nonsmoker patients exhibited the greatest number of leading saccades in the no drug condition and exhibited the most pronounced improvements after nicotine administration. Improvement in patient nonsmokers was not a function of previous smoking history. No effect of nicotine was observed in control nonsmokers. In contrast to the previous study, nicotine appeared to improve performance in control smokers. Overall, the study results support a functional role of nACh receptors in improving eye-tracking performance, and are consistent with the hypothesis, articulated by several investigators, that nACh receptor system abnormalities are responsible for a number of schizophrenia-related neurophysiological deficits.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Abel LA, Friedman L, Jesberger J, Malki A, Meltzer HY (1991). Quantitative assessment of smooth pursuit gain and catch-up saccades in schizophrenia and affective disorders. Biol Psychiatry 29: 1063–1072.
Abel LA, Ziegler AS (1988). Smooth pursuit eye movements in schizophrenic—what constitutes quantitative assessment. Biol Psychiatry 24: 747–761.
Adler LE, Hoffer LD, Wiser A, Freedman R (1993). Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150: 1856–1861.
Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K et al (1998). Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 24: 189–202.
Andreasen NC, Rice J, Endicott J, Reich T, Coryell W (1986). The family history approach to diagnosis. How useful is it? Arch Gen Psychiatry 43: 421–429.
Assad JA, Maunsell JH (1995). Neuronal correlates of inferred motion in primate posterior parietal cortex. Nature 373: 518–521.
Avila MT, McMahon RP, Elliot AR, Thaker GK (2002b). Neurophysiological markers of vulnerability to schizophrenia: sensitivity and specificity of specific quantitative eye movement measures. J Abnorm Psychol 111: 259–267.
Avila MT, Sherr JD, Hong E, Myers C, Blaxton TA, Thaker GK (2002a). Can enhanced learning explain nicotine-induced improvements in pursuit initiation in patients with schizophrenia. Program No. 705.8. 2002 Abstract Viewer/Iternary Planner, Society for Neuroscience: Washington, DC, 2002, CD-ROM.
Avila MT, Weiler MA, Lahti AC, Tamminga CA, Thaker GK (2002c). Effects of ketamine on leading saccades during smooth pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. Am J Psychiatry 159: 1490–1496.
Barnes GR, Asselman PT (1991). The mechanism of prediction in human smooth pursuit eye movements. J Physiol 439: 439–461.
Barnes GR, Barnes DM, Chakraborti SR (2000). Ocular pursuit responses to repeated, single-cycle sinusoids reveal behavior compatible with predictive pursuit. J Neurophysiol 84: 2340–2355.
Berman RA, Colby CL, Genovese CR, Voyvodic JT, Luna B, Thulburn KR et al (1999). Cortical networks subserving pursuit and saccadic eye movements in humans: an FMRI study. Hum Brain Mapp 8: 209–225.
Braun DI, Boman DK, Hotson JR (1996). Anticipatory smooth eye movements and predictive pursuit after unilateral lesions in human brain. Exp Brain Res 110: 111–116.
Breese CR, Lee MJ, Adams CE, Sullivan B, Logel J, Gillen KM et al (2000). Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 23: 351–364.
Brioni JD, Decker MW, Sulliva JP, Arneric SP (1997). The pharmacology of (−)-nicotine and novel cholinergic channel modulators. Adv Pharmacol 37: 153–212.
Chen Y, Levy DL, Nakayama K, Mattysse S, Palafox G, Holzman PS (1999). Dependence of impaired eye tracking on deficient velocity discrimination in schizophrenia. Arch Gen Psychiatry 56: 155–161.
Clementz BA, McDowell JE (1994). Smooth pursuit in schizophrenia: abnormalities of open- and closed-loop responses. Psychophysiology 31: 79–86.
Clementz BA, Reid SA, McDowell JE, Cadenhead KS (1995). Abnormality of smooth pursuit eye movement initiation: specificity to the schizophrenia spectrum? Psychophysiology 32: 130–134.
Coates KM, Flood P (2001). Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes. Br J Pharmacol 134: 871–879.
Depatie L, O'Driscoll GA, Holahan AL, Atkinson V, Thavundayil JX, Kin NN et al (2002). Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology 27: 1056–1070.
First MB, Spitzer RL, Gibbon M, Williams JW (1997). Structured Clinical Interview for DSM-IV Axis I Disorders. Biometrics Research Department: New York, NY.
Friedman L, Jesberger JA, Melzer HY (1992). Effect of typical antipsychotic medication and clozapine on smooth pursuit performance in patients with schizophrenia. Psychiatry Res 41: 25–36.
Gancarz G, Grossberg S (1999). A neural model of saccadic eye movement controls explains task-specific adaptation. Vision Res 39: 3123–3143.
George TP, Verrico CD, Picciotto MR, Roth RH (2000). Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization. J Pharmacol Exp Ther 295: 58–66.
Hilmas C, Albuquerque EX (2002). The psychotomimetic drugs phencyclidine and ketamine inhibit α7 and α4β2 nicotinic receptors: clinical implications. Program No. 242.16. 2002 Abstract Viewer/Iternary Planner, Society for Neuroscience: Washington, DC, 2002, CD-ROM.
Karoumi B, Ventre-Dominey J, Vighetto A, Darlery J, d'Amato T (1998). Saccadic eye movements in schizophrenia. Psychiatry Res 77: 9–19.
Komatsu H, Wurtz RH (1989). Modulation of pursuit eye movements by stimulation of cortical areas MT and MST. J Neurophysiol 62: 31–47.
Krauzlis RJ (2001). Extraretinal inputs to neurons in the rostral superior colliculus of the monkey during smooth-pursuit eye movements. J Neurophysiol 86: 2629–2633.
Leigh JR, Zee DS (1999). The Neurology of Eye Movements. F.A. Davis: Philadelphia, PA.
Lencer R, Malchow CP, Krecker K, Nolte A, Pinnow M, Zimmerman S et al (1999a). Smooth pursuit performance in families with multiple occurrences of schizophrenia and nonpsychotic families. Biol Psychiatry 45: 694–703.
Lencer R, Malchow CP, Trillenberg-Krecker K, Schwinger E, Arolt V (1999b). Eye-tracking dysfunction in families with sporadic and familial schizophrenia. Biol Psychiatry 47: 391–401.
Leonard S, Adler LE, Benhammou K, Berger R, Breese CR, Drebing C et al (2001). Smoking and mental illness. Pharmacol Biochem Behav 70: 561–570.
Levine G (1991). A Guide to SPSS for Analysis of Variance. Lawrence Erlbaum Associates: Hillsdale, NJ.
Levin ED, Wilson W, Rose JE, McEvoy J (1996). Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15: 429–436.
Levy DL, Holzman PS, Mendell NR (1993). Eye tracking dysfunction and schizophrenia: a critical perspective. Schizophr Bull 19: 462–501.
Levy DL, Lajonchere CM, Dorogusker B, Min D, Lee S, Tartaglini A et al (2000). Quantitative characterization of eye tracking dysfunction in schizophrenia. Schizophr Res 42: 171–185.
Lisberger SG, Morris EJ, Tychsen L (1987). Visual motion processing and sensory-motor integration for smooth pursuit eye movements. Annu Rev Neurosci 10: 97–129.
Lisberger SG, Movshon JA (1999). Visual motion analysis for pursuit eye movements in area MT of macaque monkeys. J Neurosci 19: 2224–2246.
Litman RE, Hommer DW, Radant A, Clem T, Pickar D (1994). Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia. Schizophr Res 12: 107–120.
MacAvoy MG, Gottlieb JP, Bruce CJ (1991). Smooth-pursuit eye movement representation in the primate frontal eye field. Cerebral Cortex 1: 95–102.
Maruff P, Danckert J, Pantelis C, Currie J (1998). Saccadic and attentional abnormalities in patients with schizophrenia. Psychol Med 28: 1091–1100.
Myers CS, Robles O, Kakoyannis NA, Sherr JD, Blaxton TA, Thaker GK (2002). The beneficial effects of nicotine on long-term memory in schizophrenic patients. Biol Psychiatry submitted.
Newsome WT, Wurtz RH, Komatsu H (1988). Relation of cortical areas MT and MST to pursuit eye movements. II. Differentiation of retinal from extraretinal inputs. J Neurophysiol 60: 604–620.
Olincy A, Johnson LL, Ross RG (2003). Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia. Psychiatry Res 117: 223–236.
Olincy A, Ross RG, Young DA, Roath M, Freedman R (1998). Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology 18: 175–185.
Patterson D, Nordberg A (2000). Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61: 75–111.
Petit L, Clark VP, Ingeholm J, Haxby JV (1997). Dissociation of saccade-related and pursuit-related activation in human frontal eye fields as revealed by fMRI. J Neurophysiol 77: 3386–3390.
Pfohl B, Blum N, Zimmerman M, Stangl D (1989). Structured Interview for DSM-III-R Personality (SIDP-R). University of Iowa: Iowa.
Quaia C, Lefe‘vre P, Optican LM (1999). Model of the control of saccades by superior colliculus and cerebellum. J Neurophysiol 82: 999–1018.
Radant AD, Bowdle AT, Cowley DS, Kharasch ED, Roy-Byrne PP (1998). Dose ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities? Neuropsychopharmacology 19: 434–444.
Radant AD, Hommer DW (1992). A quantitative analysis of saccades and smooth pursuit during visual pursuit tracking: a comparison of schizophrenics with normals and substance abusing controls. Schizophr Res 6: 225–235.
Robinson FR (1995). Role of the cerebellum in movement control and adaptation. Curr Opin Neurobiol 5: 755–762.
Rosenberg DR, Sweeney JA, Squires-Wheeler E, Keshavan MS, Cornblatt BA, Erlenmeyer-Kimling L (1997). Eye-tracking dysfunction in offspring from the New York High-Risk Project: diagnostic specificity and the role of attention. Psychiatry Res 66: 121–130.
Ross RG, Olincy A, Harris JG, Sullivan B, Radant A (2000). Smooth pursuit eye movements in schizophrenia and attentional dysfunction: adults with schizophrenia, ADHD, and a normal comparison group. Biol Psychiatry 48: 197–203.
Ross RG, Olincy A, Harris JG, Radant A, Adler LE, Freedman R (1998). Anticipatory saccades during smooth pursuit eye movements and familial transmission of schizophrenia. Biol Psychiatry 44: 690–697.
Ross RG, Olincy A, Harris JG, Radant A, Hawkins M, Adler LE et al (1999a). Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia. Am J Med Genet 88: 188–199.
Ross RG, Olincy A, Radant A (1999b). Amplitude criteria and anticipatory saccades during smooth pursuit eye movements in schizophrenia. Psychophysiology 36: 464–468.
Ross RG, Olincy A, Zerbe G, Radant A (2001). Which duration of postsaccadic slowing identifies anticipatory saccades during smooth pursuit eye movements. Psychophysiology 38: 325–333.
Ross DE, Thaker GK, Buchanan RW, Lahti AC, Medoff D, Bartko JJ et al (1996). Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients. Am J Psychiatry 153: 1158–1165.
Schmid A, Rees G, Frith C, Barnes G (2001). An fMRI study of anticipation and learning of smooth pursuit eye movements in humans. NeuroReport 12: 1409–1414.
Sherr JD, Meyers C, Avila MT, Elliot A, Blaxton TA, Thaker GK (2002). The effects of nicotine on specific eye tracking measures in schizophrenia. Biol Psychiatry 52: 721–728.
Stassen HH, Bridler R, Hagele S, Hergersberg M, Mehmann B, Schinzel A et al (2000). Schizophrenia and smoking: evidence for a common neurobiological basis? Am J Med Genet 96: 173–177.
Suh M, Leung HC, Kettner RE (2000). Cerebellar flocculus and ventral paraflocculus Purkinje cell activity during predictive and visually driven pursuit in monkey. J Neurophysiol 84: 1835–1850.
Sweeney JA, Clementz BA, Haas GL, Escobar MD, Drake K, Frances AJ (1994). Eye tracking dysfunction in schizophrenia: characterization of component eye movement abnormalities, diagnostic specificity, and the role of attention. J Abnorm Psychol 103: 222–230.
Sweeney JA, Luna B, Haas GL, Keshavan MS, Mann JJ, Thase ME (1999). Pursuit tracking impairments in schizophrenia and mood disorders: step-ramp studies with unmedicated patients. Biol Psychiatry 46: 671–680.
Takagi M, Zee DS, Tamargo RJ (1998). Effects of lesions of the oculomotor vermis on eye movements in primate: saccades. J Neurophysiol 80: 1911–1931.
Thaker GK (2002). Current progress in schizophrenia research: sensory gating deficit in schizophrenia: is the nicotinic alpha-7 receptor implicated? J Nerv Ment Dis 190: 550–551.
Thaker GK, Ellsberry MM, Lahti A, Tamminga C (1991). Tobacco smoking increases square-wave jerks during pursuit eye movements. Biol Psychiatry 29: 82–88.
Thaker GK, Ross DE, Buchanan RW, Adami HM, Medoff DR (1999). Smooth pursuit eye movements to extraretinal motion signals: deficits in patients with schizophrenia. Psychiatry Res 88: 209–219.
Thaker GK, Ross DE, Buchanan RW, Moran MJ, Lahti A, Kim CE et al (1996). Does pursuit abnormality in schizophrenia represent a deficit in the predictive mechanism? Psychiatry Res 59: 221–237.
Thaker GK, Ross DE, Cassady S, Adami HM, Laporte D, Medoff DR et al (1998). Smooth pursuit eye movements to extraretinal motion signals. Arch Gen Psychiatry 55: 830–836.
Turano KA, Heidenreich SM (1999). Eye movements affect the perceived speed of visual motion. Vision Res 39: 1177–1187.
Turano KA, Massof RW (2001). Nonlinear contribution of eye velocity to motion perception. Vision Res 41: 385–395.
van den Berg AV (1988). Human smooth pursuit during transient perturbations of predictable and unpredictable target movement. Exp Brain Res 72: 95–108.
Van Gelder P, Lebedev S, Liu PM, Tsui WH (1995). Anticipatory saccades in smooth pursuit: task effects and pursuit vector after saccades. Vision Res 35: 667–678.
Weiler MA, Thaker GK, Lahti AC, Tamminga CA (2000). Ketamine effects on eye movements. Neuropsychopharmacology 23: 645–653.
Whicker L, Abel LA, Dell'Osso LF (1985). Smooth pursuit eye movements in the parents of schizophrenics. Neuro-ophthalmology 5: 1–8.
Acknowledgements
The work presented was supported by NIH Grants MH49826 and MH40279, General Clinical Research Centers Grant # M01 RR 165001, and a Research Cooperation Agreement with Novartis. We acknowledge the contributions of Healthy Langley and John Schreiber, who assisted in collecting and processing the eye movement data.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Avila, M., Sherr, J., Hong, E. et al. Effects of Nicotine on Leading Saccades during Smooth Pursuit Eye Movements in Smokers and Nonsmokers with Schizophrenia. Neuropsychopharmacol 28, 2184–2191 (2003). https://doi.org/10.1038/sj.npp.1300265
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300265
Keywords
This article is cited by
-
Effects of nicotine on smooth pursuit eye movements in healthy non-smokers
Psychopharmacology (2019)
-
Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation
Translational Psychiatry (2015)
-
Small effects of smoking on visual spatiotemporal processing
Scientific Reports (2014)
-
Smoking improves divided attention in schizophrenia
Psychopharmacology (2014)
-
Targeting the Nicotinic Cholinergic System to Treat Attention-Deficit/Hyperactivity Disorder: Rationale and Progress to Date
CNS Drugs (2014)
